Long noncoding RNA expression analysis in Crimean Congo hemorrhagic fever patients

Area of Science:

• Molecular Biology
• Virology
• Genomics

Background:

• Crimean-Congo hemorrhagic fever (CCHF) is a severe viral illness with high mortality.
• Understanding host gene expression, particularly long noncoding RNAs (lncRNAs), is crucial for CCHF pathogenesis.
• lncRNAs play vital roles in gene regulation and are potential therapeutic targets.

Purpose of the Study:

• To investigate lncRNA gene expression profiles in CCHF patients for the first time.
• To identify differentially expressed lncRNAs between healthy controls and CCHF cases, including fatal outcomes.
• To validate key lncRNAs as potential therapeutic targets for CCHF.

Main Methods:

• Microarray analysis was used to profile lncRNA expression in CCHF cases and controls.
• Statistical comparisons were made between case-control, fatal case-control, and fatal case-nonfatal groups.
• Quantitative polymerase chain reaction (qPCR) was employed to validate microarray findings for selected lncRNAs.

Main Results:

• 39 lncRNAs were significantly regulated in CCHF cases versus controls (5 downregulated, 34 upregulated).
• 110 lncRNAs showed significant differences between fatal CCHF cases and controls.
• FER1L4, ECRP, and LOC100133669 were identified as important lncRNAs in both case and fatal case groups.

Conclusions:

• This study provides the first comprehensive lncRNA expression profile in CCHF.
• Specific lncRNAs, including FER1L4, ECRP, and LOC100133669, are significantly associated with CCHF and its severity.
• These identified lncRNAs represent promising therapeutic targets for future CCHF treatment strategies.